Although the anti-inflammatory, anti-atherosclerotic, and antithrombotic effects of IL-10 are known, a prospective study suggested that elevated serum levels of IL-10 are associated with an increased risk of cardiovascular events in patients with CKD [98]. This evidence concerns the gene IL10 and chronic kidney disease.